Camilla Jessen
Check if yours is affected.
The U.S. Food and Drug Administration (FDA) has announced a nationwide recall of over 141,000 bottles of a popular cholesterol-lowering drug, citing a failure to meet dissolution specifications.
The recall affects Atorvastatin Calcium tablets, the generic form of Lipitor, manufactured by Ascend Laboratories, LLC.
The issue relates to how the tablets dissolve in the body, which may impact how effectively the drug works.
Which medications are affected?
The recall includes multiple strengths and pill counts of Atorvastatin Calcium, including 10 mg, 20 mg, 40 mg, and 80 mg tablets.
The affected products were distributed in 90-count, 500-count, and 1,000-count bottles with expiration dates ranging from June 2026 to February 2027.
Here are some of the affected lot numbers and expiration dates:
- 10 mg: Lot codes include 25141249; 24144938; 24144868; 24144867; 24144458; 24143994; 24142987; 24143316 | Expires Feb. 2027 to July 2026
- 20 mg: Lot codes include 25140150; 25140173; 25140172; 24144720; 24144798; 24144692; 24143755; 24143913; 24143754; 24143047; 24142936 | Expires Dec. 2026 to June 2026
- 40 mg: Lot codes include 25140933; 25140477; 24144254; 24144163; 24143995 | Expires Feb. 2027 to Sept. 2026
- 80 mg: Lot codes include 25140249; 25140247; 24144999; 24144942; 24144845; 24144713; 24144652; 24143898; 24143412; 24143582 | Expires Dec. 2026 to Aug. 2026
Full lot and expiration details can be found on the product label or bottle.
What you should do
The recall has been classified as a Class II, meaning the affected products could cause temporary or medically reversible health issues. There are no reports of serious harm at this time.
Patients taking Atorvastatin should check their medication labels and contact their pharmacy or healthcare provider if their product is part of the recall.
For more information or to report a problem, contact the FDA.
This article is made and published by Camilla Jessen, who may have used AI in the preparation
